Literature DB >> 1894597

Novel mechanism of intracellular calcium release in pituitary cells.

H Koshiyama1, H C Lee, A H Tashjian.   

Abstract

In sea urchin eggs an enzymatic metabolite of beta-NAD+, called cyclic ADP-ribose (cADPR), is as potent and powerful a releaser of sequestered intracellular Ca2+ as is inositol 1,4,5-trisphosphate (IP3). The enzyme that synthesizes cADPR is present in several vertebrate animal tissues, but the Ca(2+)-releasing activity of cADPR has not been described in mammalian cells. We report here that incubation of beta-NAD+ with cell-free extracts of several rat tissues (including pituitary gland) generates a product which releases intracellular Ca2+ stores in permeabilized rat pituitary GH4C1 cells. This product has the biological characteristics of cADPR (it acts after depletion of the IP3 stores and after blockade of the IP3 receptor by heparin). The response is mimicked, in a concentration-dependent manner, by authentic cADPR and is desensitized by prior incubation with cADPR. We conclude that cADPR is not only synthesized by certain mammalian cells but also acts in such cells to release compartmentalized intracellular Ca2+ by a mechanism that differs from that used by IP3. Therefore, cADPR may serve, in addition to IP3, as a second messenger for intracellular Ca2+ mobilization in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1894597

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Site-directed removal of N-glycosylation sites in BST-1/CD157: effects on molecular and functional heterogeneity.

Authors:  S Yamamoto-Katayama; A Sato; M Ariyoshi; M Suyama; K Ishihara; T Hirano; H Nakamura; K Morikawa; H Jingami
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

Review 2.  NAD glycohydrolases: a possible function in calcium homeostasis.

Authors:  H Kim; E L Jacobson; M K Jacobson
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

3.  The action of extracellular NAD+ on gluconeogenesis in the perfused rat liver.

Authors:  Adriana G Martins; Jorgete Constantin; Fabrício Bracht; Ana Maria Kelmer-Bracht; Adelar Bracht
Journal:  Mol Cell Biochem       Date:  2006-04-21       Impact factor: 3.396

4.  A monoclonal antibody against a murine CD38 homologue delivers a signal to B cells for prolongation of survival and protection against apoptosis in vitro: unresponsiveness of X-linked immunodeficient B cells.

Authors:  Y Yamashita; K Miyake; Y Kikuchi; K Takatsu; S Noda; A Kosugi; M Kimoto
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

Review 5.  Cyclic ADP-ribose: a calcium mobilizing metabolite of NAD+.

Authors:  H C Lee
Journal:  Mol Cell Biochem       Date:  1994-09       Impact factor: 3.396

6.  Cyclic ADP-Ribose and NAADP in Vascular Regulation and Diseases.

Authors:  Pin-Lan Li; Yang Zhang; Justine M Abais; Joseph K Ritter; Fan Zhang
Journal:  Messenger (Los Angel)       Date:  2013-06-01

7.  Activation of Ca(2+)-dependent currents in cultured rat dorsal root ganglion neurones by a sperm factor and cyclic ADP-ribose.

Authors:  K P Currie; K Swann; A Galione; R H Scott
Journal:  Mol Biol Cell       Date:  1992-12       Impact factor: 4.138

8.  Two calcium-binding sites mediate the interconversion of liver inositol 1,4,5-trisphosphate receptors between three conformational states.

Authors:  I C Marshall; C W Taylor
Journal:  Biochem J       Date:  1994-07-15       Impact factor: 3.857

9.  Transformation and actions of extracellular NADP(+) in the rat liver.

Authors:  Ana Carla Broetto-Biazon; Monica Mendes Kangussu; Fábio Padilha; Fabrício Bracht; Ana Maria Kelmer-Bracht; Adelar Bracht
Journal:  Mol Cell Biochem       Date:  2008-06-13       Impact factor: 3.396

10.  Calmodulin is a selective mediator of Ca(2+)-induced Ca2+ release via the ryanodine receptor-like Ca2+ channel triggered by cyclic ADP-ribose.

Authors:  Y Tanaka; A H Tashjian
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.